Clinical Trial Update: Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating caspofungin-based combination antifungal therapy for proven or probable invasive fungal infection in patients with leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection
• Leukemia

Drugs mentioned

• Caspofungin (Cancidas) (caspofungin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Leukemia, Transplantation, Hematopoietic Stem Cell | Phase 2 | Status: UNKNOWN